A study of multidrug-resistant tuberculosis in risk groups in the city of Santos, São Paulo, Brazil
AUTOR(ES)
Coelho, Andréa Gobetti Vieira, Zamarioli, Liliana Aparecida, Telles, Maria Alice, Ferrazoli, Lucilaine, Waldman, Eliseu Alves
FONTE
Mem. Inst. Oswaldo Cruz
DATA DE PUBLICAÇÃO
2012-09
RESUMO
Monitoring the extent of and trends in multidrug-resistant tuberculosis (MDR-TB) is a priority of the Brazilian National Tuberculosis Control Programme. The current study aimed to estimate the incidence of MDR-TB, describe the profile of TB drug resistance in risk groups and examine whether screening for MDR-TB adhered to the recommended guidelines. A descriptive study that examined diagnosed cases of pulmonary TB was conducted in the city of Santos, Brazil, between 2000-2004. Of the 2,176 pulmonary TB cases studied, 671 (30.8%) met the criteria for drug sensitivity testing and, of these cases, 31.7% (213/671) were tested. Among the tested cases, 9.4% were resistant to one anti-TB drug and 15% were MDR. MDR was observed in 11.6% of 86 new TB cases and 17.3% of 127 previously treated cases. The average annual incidence of MDR-TB was 1.9 per 100,000 inhabitants-years. The extent of known MDR-TB in the city of Santos is high, though likely to be underestimated. Our study therefore indicates an inadequate adherence to the guidelines for MDR-TB screening and suggests the necessity of alternative strategies of MDR-TB surveillance.
Documentos Relacionados
- Multidrug-resistant urinary tract isolates of escherichia coli from Ribeirão Preto, São Paulo, Brazil
- Multidrug-resistant tuberculosis
- Multidrug-resistant tuberculosis: case reports study in a central state of Brazil
- Primary bacillary resistance in multidrug-resistant tuberculosis and predictive factors associated with cure at a referral center in São Paulo, Brazil
- Trends in multidrug-resistant tuberculosis